Theraclion

About:

Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound.

Website: http://www.theraclion.com/

Top Investors: Truffle Capital, Nice & Green SA

Description:

Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They offer an innovative echotherapy solution that combines HIFU therapy with ultrasound as a system for locating target areas for the non-invasive treatment of benign tumors and varicose veins. Their companyTheraclion a French company created in 2004, a pioneer in the use of ultrasound for therapeutic purposes. Theraclion develops, manufactures, and markets medical devices, the Echopulse®, for non-invasive and ambulatory treatment of breast fibroadenomas and benign thyroid nodules. And the SONOVEIN® for the treatment of varicose veins of the lower limbs.

Total Funding Amount:

$5.69M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Malakoff, Ile-de-France, France

Founded Date:

2004-01-01

Contact Email:

contact(AT)theraclion.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2019-03-04

IPO Status:

Public

Industries:

© 2025 bioDAO.ai